Monoaminergic stabilisers

OSU6162 is a compound that exerts stabilising effects on dopaminergic and serotonergic transmission, and on psychomotor activity. OSU6162 can both stimulate and inhibit behaviour depending on the baseline activity level. OSU6162 has shown promising results in several clinical trials and has a remarkably mild side effect profile. OSU6162 has so far been tested in Parkinson’s disease, Huntington's disease, mental fatigue following stroke or traumatic brain injury, myalgic encephalomyelitis, narcolepsy and schizophrenia.